Literature DB >> 20739540

Modification of human papillomavirus minor capsid protein L2 by sumoylation.

Martina Bergant Marusic1, Nina Mencin, Mia Licen, Lawrence Banks, Helena Sterlinko Grm.   

Abstract

The human papillomavirus (HPV) minor capsid protein L2 plays important roles in the generation of infectious viral particles and in the initial steps of infection. Here we show that HPV-16 L2 protein is sumoylated at lysine 35 and that sumoylation affects its stability. Interestingly, the sumoylated form of L2 cannot bind to the major capsid protein L1, suggesting a mechanism by which capsid assembly may be modulated in an infected cell. Additionally, L2 appears to modulate the overall sumoylation status of the host cell. These observations indicate a complex interplay between the HPV L2 protein and the host sumoylation machinery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20739540      PMCID: PMC2953202          DOI: 10.1128/JVI.01269-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  SUMO-1 modification of bovine papillomavirus E1 protein is required for intranuclear accumulation.

Authors:  D Rangasamy; K Woytek; S A Khan; V G Wilson
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

2.  A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers.

Authors:  Germán Rosas-Acosta; William K Russell; Adeline Deyrieux; David H Russell; Van G Wilson
Journal:  Mol Cell Proteomics       Date:  2004-11-30       Impact factor: 5.911

3.  The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle.

Authors:  Sigrid C Holmgren; Nicole A Patterson; Michelle A Ozbun; Paul F Lambert
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation.

Authors:  J M Desterro; M S Rodriguez; R T Hay
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

5.  Sequences required for the nuclear targeting and accumulation of human papillomavirus type 6B L2 protein.

Authors:  X Y Sun; I Frazer; M Müller; L Gissmann; J Zhou
Journal:  Virology       Date:  1995-11-10       Impact factor: 3.616

6.  Human papillomavirus 16 L2 inhibits the transcriptional activation function, but not the DNA replication function, of HPV-16 E2.

Authors:  A Okoye; P Cordano; E R Taylor; I M Morgan; R Everett; M S Campo
Journal:  Virus Res       Date:  2005-03       Impact factor: 3.303

7.  Interactions between papillomavirus L1 and L2 capsid proteins.

Authors:  Renée L Finnen; Kimberly D Erickson; Xiaojiang S Chen; Robert L Garcea
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

8.  Proteins of the PIAS family enhance the sumoylation of the papillomavirus E1 protein.

Authors:  Germán Rosas-Acosta; Martijn A Langereis; Adeline Deyrieux; Van G Wilson
Journal:  Virology       Date:  2005-01-05       Impact factor: 3.616

Review 9.  Viral entry mechanisms: human papillomavirus and a long journey from extracellular matrix to the nucleus.

Authors:  Martin Sapp; Malgorzata Bienkowska-Haba
Journal:  FEBS J       Date:  2009-12       Impact factor: 5.542

10.  Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence.

Authors:  J Zhou; X Y Sun; K Louis; I H Frazer
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

View more
  25 in total

Review 1.  Human pathogens and the host cell SUMOylation system.

Authors:  Peter Wimmer; Sabrina Schreiner; Thomas Dobner
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  Viral manipulation of cellular protein conjugation pathways: The SUMO lesson.

Authors:  Domenico Mattoscio; Chiara V Segré; Susanna Chiocca
Journal:  World J Virol       Date:  2013-05-12

Review 3.  Papillomavirus assembly: An overview and perspectives.

Authors:  Carla Cerqueira; John T Schiller
Journal:  Virus Res       Date:  2016-11-10       Impact factor: 3.303

4.  Human Papillomavirus infection requires the CCT Chaperonin Complex.

Authors:  Marina Bugnon Valdano; Paola Massimi; Justyna Broniarczyk; David Pim; Michael Myers; Daniela Gardiol; Lawrence Banks
Journal:  J Virol       Date:  2021-03-17       Impact factor: 5.103

5.  Human papillomavirus L2 facilitates viral escape from late endosomes via sorting nexin 17.

Authors:  Martina Bergant Marušič; Michelle A Ozbun; Samuel K Campos; Michael P Myers; Lawrence Banks
Journal:  Traffic       Date:  2012-01-08       Impact factor: 6.215

6.  Sumoylation of the P protein at K254 plays an important role in growth of parainfluenza virus 5.

Authors:  Dengyun Sun; Pei Xu; Biao He
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

7.  Incoming human papillomavirus 16 genome is lost in PML protein-deficient HaCaT keratinocytes.

Authors:  Malgorzata Bienkowska-Haba; Wioleta Luszczek; Timothy R Keiffer; Lucile G M Guion; Stephen DiGiuseppe; Rona S Scott; Martin Sapp
Journal:  Cell Microbiol       Date:  2017-01-23       Impact factor: 3.715

8.  Phosphorylation of Human Papillomavirus Type 16 L2 Contributes to Efficient Virus Infectious Entry.

Authors:  Justyna Broniarczyk; Paola Massimi; David Pim; Martina Bergant Marušič; Michael P Myers; Robert L Garcea; Lawrence Banks
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

Review 9.  L2, the minor capsid protein of papillomavirus.

Authors:  Joshua W Wang; Richard B S Roden
Journal:  Virology       Date:  2013-05-17       Impact factor: 3.616

10.  SUMOylation affects the interferon blocking activity of the influenza A nonstructural protein NS1 without affecting its stability or cellular localization.

Authors:  Andres Santos; Sangita Pal; Jason Chacón; Katherine Meraz; Jeanette Gonzalez; Karla Prieto; Germán Rosas-Acosta
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.